PVI
IMGN

Pura Vida Investments’s Immunogen Inc IMGN Stock Holding History

Pura Vida Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-484,600
Closed -$3.6M – 300
2021
Q4 		$3.6M Sell
484,600
-166,100
-26% -$1.03M 0.13% 127
2021
Q3 		$3.69M Buy
+650,700
New +$3.76M 0.11% 164

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's IMGN Position: Q1 2023 in Review

Pura Vida Investments sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 50,000 shares — an estimated $248K sold.

Pura Vida Investments first reported a position in IMGN in Q4 2020 and held it in 6 quarters. The position peaked at $6.51M in Q1 2021. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Pura Vida Investments reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Immunogen Inc shares in Q1 2023, an estimated $248K.
  • Pura Vida Investments first reported a position in Immunogen Inc in Q4 2020 and held it in 6 quarters.
  • Pura Vida Investments's Immunogen Inc position peaked at $6.51M in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.